Indications for fetal echocardiography

Pediatric Cardiology

Volumn 25, Issue 3, 2004, Pages 210-222

  Small, M ^a   Copel, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Congenital anomalies; Congenital heart defects; Diabetes mellitus; Fetal echocardiography; Nuchal translucency; Prenatal diagnosis

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; ISOTRETINOIN; LITHIUM CARBONATE; PHENYTOIN; RETINOL; RETINOL DERIVATIVE; TOPICAL AGENT; TRIMETHADIONE; VALPROIC ACID;

CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; DIABETES MELLITUS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FAMILY HISTORY; FETUS ECHOCARDIOGRAPHY; FETUS ECHOGRAPHY; FETUS MALFORMATION; HIGH RISK POPULATION; HUMAN; MATERNAL DISEASE; PRENATAL DIAGNOSIS; PRENATAL DRUG EXPOSURE; REVIEW; RISK FACTOR; TERATOGENICITY;

EID: 2642562091     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0587-z     Document Type: Review

References (114)

1. Abuhamad A (1997) A Practical Guide to Fetal Echocardiography. Lippincott-Raven, Philadelphia
2. Allan LD, Crawford DC, Chita SK, Anderson RH, Tynan MJ (1986) Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 58:334-337
3. Antolin E, Comas C, Torrents M, et al. (2001) The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 17:295-300
4. Apkon M (1995) Pathophysiology of hydrops fetalis. Sem Perinatol 19:437-446
5. Ardinger HH, Atkin JF, Blackston RD, et al. (1988) Verification of the fetal valproate syndrome phenotype. Am J Med Genet 29:171-185
6. Askaase AD, Friedman DM, Copel J, et al. (2002) Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 11:145-151
7. Bahado-Singh RO, Rowther M, Bailey J, et al. (2002) Mid-trimester nuchal thickness and the prediction of postnatal congenital heart defect. Am J Obstet Gynecol 187:1137-1142
8. Bashat AA, Gembruch U, Knopfle, et al. (1999) First trimester fetal heart block: a marker for cardiac anomaly. Ultrasound Obstet Gynecol 14:311-314
9. Baumann P, Copel JA, Kleinman CS (1992) Management of the fetus with cardiac disease. Ultrasound Q 10:57-58
10. Becerra JE, Khoury MJ, Cordero JF, Erickson JD (1990) Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9
11. Benacerraf BR, Frigoletto FD (1987) Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol 157:1146-1149
12. Benacerraf BR, Gelman R, Frigoletto F (1987) Sonographic identification of second trimester fetuses with Down syndrome. N Engl J Med 317:1371-1376
13. Bianci D, Crombleholme T, D'Alton M (2000) Fetology: Diagnosis and Management of the Fetal Patient. McGraw-Hill, New York
14. Bilardo CM, Muller MA, Zikulnig L, et al. (2001) Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 17:288-294
15. Boughman JA, Berg KA, Astemborski JA, et al. (1987) Familial risks of congenital heart defect in a population-based epidemiological study. Am J Med Genet 26:839-849
16. Budorick N, Millman S (2000) New modalities for imaging the fetal heart. Sem Perinatol 5:352-359
17. Bunyon JP, Clancey R, Di Donato F, et al. (2002) Cardiac 5-HT serotoninergic receptors, 52KD SSA/Ro and autoimmune-associated congenital heart block. J Autoimmun 19:79-86
18. Burn J, Brennan P, Little J, et al. (1998) Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351:311-316
19. Buyon JP (1999) Neonatal lupus syndrome. In: Lahita RG (Eds.), Systemic Lupus Erythematosus, 3rd ed. Academic Press, San Diego
20. Buyon JP, Clancy R, Di Donate F, et al. (2002) Cardiac 5-HT serotoninergic receptors, 52KD SSA/Ro and autoimmune-associated congenital heart block. J Autoimmun 19:79-86
21. Buyon JP, Hiebert R, Copel JA, et al. (1998) Autoimmune-associated congenital heart block: mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658-1666
22. Carlson, DE, Platt LD, Medearis AL, Horenstein J (1990) Quantifiable polyhydramnios: diagnosis and management. Obstet Gynecol 75:989-993
23. Chameides L, Truex RC, Vetter V, et al. (1977) Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 297:1204-1207
24. Comstock, CH (1987) Normal fetal heart axis and position. Obstet Gynecol 70:255-259
25. Copel JA, Pilu G, Green J, Hobbins JC, Kleinman CS (1987) Fetal echocardiographic screening for congenital heart disease: the importance of the four chamber view. Am J Obstet Gynecol 157:648-655
26. Copel JA, Pilu G, Kleinman CS (1986) Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol 154:1121-1132
27. Copel JA, Pilu G, Kleinman CS (1993) Extracardiac anomalies and congenital heart disease. Sem Perinatol 17:89-105
28. Crane J, Ash K, Desjardins (1997) Abnormal fetal cardiac axis in the detection of intrathoracic anomalies and congenital heart disease. Ultrasound Obstet Gynecol 10:90-93
29. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F (1987) Anticonvulsants, folate levels, and pregnancy outcome: a prospective study. Ann Neurol 21:176-182
30. Dashe J, McIntire D, Ramus R, Santos-Ramos R, Twickler D (2002) Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol 100:134-139
31. Devine PC, Simpson L (2000) Nuchal translucency and its relationship to congenital heart disease. Sem Perinatol 5:343-351
32. Eftekhari P, Salle L, Lezoulach F, et al. (2000) Anti-SSA/Ro52 autoantibodies blocking the cardiac 5HT4 serotonergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 30:2782-2790
33. Esscher E, Scott JS (1979) Congenital heart block and maternal systemic lupus erythematosus. Br Med J 1:1235-1238
34. Ewigman BG, Crane JP, Frigoletto FD, et al. (1993) A randomized trial of prenatal ultrasound screening in a low risk population: impact on perinatal outcome. N Engl J Med 329:821-827
35. Ferencz C, Rubin JD, McCarter RJ, et al. (1985) Congenital heart disease: prevalence at live birth. The Baltimore-Washington Infant Study. Am J Epidemiol 121:31-36
36. Fermont L, DeGeeterr B, Aubry J (1986) A close collaboration between obstetricians and pediatric cardiologists allows antenatal detection of severe cardiac malformations by 2D echocardiography. In: Doyle EF, Engle ME, Gersony WM (Eds.), Pediatric Cardiology: Proceedings of the Second World Congress. Springer-Verlag, New York, pp 34-367
37. Friedman A, Copel JA, Kleinman C, et al. (1993) Fetal echocardiography and fetal cardiology: indications, diagnosis and management. Sem Perinatol 17:76-88
38. Gallager P, Mahoney M, Gosche J (1999) Cystic hygroma in the fetus and newborn. Sem Perinatol 23:341-356
39. Gembruch U, Holtzgreve W (2000) The fetus with nonimmune hydrops fetalis. In: Harrison M, Evans M, Adzick, Holtzgreve W (Eds.), The Unborn Patient: The Art and Science of Fetal Therapy, 3rd ed. Saunders, Philadelphia
40. Glickstein J, Buyon J, Friedman D (2000) Pulsed echocardiographic assessment of the fetal PR interval. Am J Cardiol 86:236-239
41. Haak, MC, Twisk JW, Van Vugt JM (2002) How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol 20:9-13
42. Hagay Z, Reece E (1995) Diabetes mellitus in pregnancy. In: Reece EA, Coustan DR (Eds.), Medicine of the Fetus and Mother, 2nd ed. Churchill Livingstone, New York
43. Hanson JW, Myrianthopoulos NC, Harvey MAS, Smith DW (1976) Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89:662-668
44. Hecher, K (2001) Opinion: assessment of ductus venosus flow during the first and early second trimesters: what can we expect? Ultrasound Obstet Gynecol 17:285-287
45. Hegge FN, Lees MH, Watson PT (1987) Utility of a screening examination of the fetal cardiac position and four chambers during obstetric sonography. J Reprod Med 32:353-358
46. Hoffman JIE, Christianson R (1978) Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 42:641-647
47. Holtzgreve W, Holtzgreve B, Curry CJR (1985) Non-immune hydrops fetalis: diagnosis and management. Sem Perinatol 9:52-67
48. Huggon IC, Ghi T, Cook AC, et al. (2000) Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 20:22-29
49. Hyett JA, Moscosco G, Nicolaides KH (1995) First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am J Obstet Gynecol 172:1411-1413
50. Hyett J, Moscoso G, Papanagiotou G, Perdu M, Nicolaides KH (1996) Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7:245-250
51. Hyett JA, Perdu M, Gurleen S, Snijders R, Nicolaides K (1999) Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population-based cohort study. Br Med J 318:81-85
52. Hyett JA, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH (1997) Increased nuchal translucency at 10-14 weeks as a marker of major cardiac defects. Ultrasound Obstet Gynecol 10:242-246
53. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340:1449-1454
54. Jaeggi ET, Fouron JC, Proulx F (2001) Fetal cardiac performance in uncomplicated and well-controlled maternal type 1 diabetes. Ultrasound Obstet Gynecol 17:311-315
55. Jick SS, Terris BZ, Jick H (1993) First trimester topical retinoin and congenital disorders. Lancet 341: 1181-1182
56. Johnson MP, Johnson A, Holzgrev W, et al. (1993) First-trimester cystic hygroma; cause and outcome. Am J Obstet Gynecol 168:156-161
57. Jones DC (1995) Non-immune hydrops fetalis. Sem Perinatol 19:447-461
58. Jones KL, Lacro RV, Johnson KA, Adams J (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666
59. Junker R, Kotthoff S, Vielhaber H. et al. (2001) Infant methylenetetrahydrofolate reductase C677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 51:251-254
60. Kirk JS, Riggs TW, Comstock CH, et al. (1994) Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four-chamber view. Obstet Gynecol 84:427-431
61. Kisserud T, Eik-Nes SH (1995) The fetal ductus venosus. Doppler Ultra sound in Obstetrics and Gynecology. Raven Press, New York,
62. Kleinert S (1996) Routine prenatal screening for congenital heart disease. Lancet 348:836
63. Kleinman C, Donnerstein R, DeVore G, et al. (1982) Fetal echocardiography for evaluation of in utero congestive heart failure: a technique for study of nonimmune fetal hydrops. N Engl J Med 306:568-575
64. Kleinman CS, Copel JA, Hobbins JC (1987) Combined echocardiographic and Doppler assessment of fetal congenital atrioventricular block. Br J Obstet Gynaecol 94:967-974
65. Lee LA, Reed BR, Harmon C (1983) Autoantibodies to SS-A/Ro in congenital heart block. Arthritis Rheum 20:S24
66. Lenke RR, Levy HL (1980) Maternal phenylketonuria and hyperphenylananinemia: an international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303:1202-1208
67. Levy H, Guldberg P, Guttler F, et al. (2001) Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr Res 49:636-642
68. Lockshin M (1990) Pregnancy associated with systemic lupus erythematosus. Sera Perinatol 14:130-138
69. Luck CA (1992) Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries. Br Med J 304:1474-1478
70. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH (1999) Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 14:307-310
71. McCue CM, Mantakas ME, Tingelstad JB (1977) Congenital heart block in newborns of mothers with connective tissue disease. Circulation 56:82-90
72. Menashe M, Arbel R, Raveh D, Achiron R, Yages S (2002) Poor prenatal detection rate of cardiac anomalies in Noonan syndrome. Ultrasound Obstet Gynecol 19:51-55
73. Miller E, Hare JW, Cloherty JP, et al. (1981) Elevated maternal hemoglobin Alc in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 302:1331-1334
74. Mills JL, Kirke PN, Molloy AM, et al. (1999) Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 86:71-74
75. Mills JL, McPartlin JM, Kirke PN (1995) Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151
76. Miranda-Carus ME, Tseng CE, Rashbaum RL, et al. (1998) Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 161:5061
77. Moller JH (1990) Incidence of cardiac malformations. In: Moller JH, Neal WA (Eds.), Fetal, Neonatal and Infant Cardiac Disease. Appleton & Lange, Norwalk, CT. pp 361-369
78. Monson RR, Rosenberg L, Hartz SC, et al. (1973) Diphenylhydantoin and selected congenital malformations. N Engl J Med 289:1049-1052
79. Moore T (1999) Diabetes in pregnancy. In: Creasy R, Resnik R (Eds.), Maternal Fetal Medicine, 4th ed. Saunders, Philadelphia
80. MRC Vitamin Study Research Group(1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137
81. Nicolaides K, Sebire N, Snijders M (1999) The 11-14 Week Scan: The Diagnosis of Fetal Abnormalities. Parthenon, New York
82. Nicolaides KH, Snijders RJM, Gosden CM, Campbell S (1992) Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340:704-707
83. Nora JJ, Nora AH, Takao A (1984) Congenital Heart Disease: Causes and Processes. Futura, Mt. Kisco, NYpp 3-13
84. Platt LD, Koch R, Azen C, et al. (1992) Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years. Am J Obstet Gynecol 166:1150-1160
85. Platt LD, Koch R, Hanley W, et al. (2000) The International Study of Pregnancy Outcome in Women with Maternal Phenylketonuria: report of a 12-year study. Am J Obstet Gynecol 182:326-333
86. Reece E, Coustan D (1995) Diabetes Mellitus in Pregnancy, 2nd ed. Churchill Livingstone, New York
87. Romero R, Pilu G, Jeanty A, Ghidini A, Hobbins J (1988) Prenatal Diagnosis of Congenital Anomalies. Appleton & Lange, Norwalk, CT
88. Rose V, Gold RJM, Lindsay G, Allen M (1985) A possible increase in the incidence of congenital heart defects among offspring of affected parents. J Am Cardiol 6:376-382
89. Rothman KJ, Moore LL, Singer MR, et al. (1995) Teratogenicity of high vitamin A intake. N Engl J Med 333:1369-1373
90. Rowland TW, Hubbell Jr JP, Nadas AS (1973) Congenital heart disease in infants of diabetic mothers. J Pediatr 83:815-820
91. Rustico MA, Benettoni A, D'Ottavio G, et al. (1995) Fetal heart screening in low-risk pregnancies. Ultrasound Obstet Gynecol 6:1-7
92. Saleeb S, Copel J, Friedman D, et al. (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335-2345
93. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA (1991) Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 91:1360-1366
94. Scott JS, Maddison PJ, Taylor PV, et al. (1983) Connective-tissue disease, antibodies to riobnucleoprotein, and congenital heart block. N Engl J Med 309:209-212
95. Shenker L, Reed KL, Anderson CF, et al. (1987) Congenital heart block and cardiac anomalies in the absence of maternal connective tissue disease. Am J Obstet Gynecol 157:248
96. Shields LE, Gan EA, Murphy CNM, Sahn DJ, Moore TR (1993) The prognostic value of hemoglobin Alc in predicting fetal heart disease in diabetic pregnancies. Obstet Gynecol 81:954-957
97. Shipp TD, Bromley B, Hornberger LK, Nadel A, Benacerraf BR (1995) Levorotation of the fetal cardiac axia: a clue for the presence of congenital heart disease. Obstet Gynecol 85:97-102
98. Shirley IM, Bottomley F, Robinson VP (1992) Routine radiographer screening for fetal abnormalities by ultrasound in an unselected low risk population. Br J Radiol 65:564-569
99. Silverman NH, Kleinman CS (1987) Fetal echocardiographic screening for congenital heart disease: the importance of the four chamber view. Am J Obstet Gynecol 157:648-655
100. Smith RS, Comstock CH, Kirk JS, Lee W (1995) Ultrasonographic left cardiac axis deviation: a marker for fetal anomalies. Obstet Gynecol 85:187-191
101. Smythe JF, Copel JA, Kleinman CS (1992) Outcome of prenatally detected cardiac malformations. Am J Cardiol 69:1471-1474
102. Snijders RJM, Noble P, Seibire N, Souka A, Nicolaides KH, for the Fetal Medicine Foundation First Trimester Screening Group (1998) UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency at 10-14 weeks of gestation. Lancet 352:343-346
103. Steven J, Whitsett JA (1979) Insulin binding to neonatal human, guinea pig and rat myocardial membranes. Pediatr Res 13:482
104. Stumfplen I, Stumfplen A, Wimmer M, Bernaschek G (1996) Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 348:854-857
105. Todros T, Faggiano F, Chiappa E, et al. (1997) Accuracy of routine ultrasonography in screening heart disease prenatally. Prenat Diagn 17:901-906
106. Vergani P, Mariani S, Ghidina A, et al. (1992) Screening of congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol 167:1000-1003
107. Weber HS, Copel JA, Reece EA, et al. (1991) Cardiac growth in fetuses of diabetic mothers with good metabolic control. J Pediatr 118:103
108. Wenstrom K, Johanning G, Johnston K, DuBard M (2001) Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 184:806-817
109. Whittemore R, Hobbins JC, Engle MA (1982) Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 50:641-651
110. Wyllie J, Wren C, Hunter S (1994) Screening for fetal cardiac malformations. Br Heart J 71:(suppl)20-27
111. Yagel S, Weissman A, Rotsetin Z, et al. (1997) Congenital heart defects: natural course and in utero development. Circulation 96:550-555
112. Zackai EH, Mellman WJ, Neiderer B, Hanson JW (1975) The fetal trimethadione syndrome. J Pediatr 87:280-284
113. Zierler S (1985) Maternal drugs and congenital heart disease. Obstet Gynecol 65:155-165
114. Zierler S, Rothman KJ (1985) Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 313:347-352